Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease

Lily Zhang, Carolina Mercado, Anat Galor, Edward J. Holland, Gaofeng Wang, Carol Karp

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Few studies have described ocular surface squamous neoplasia (OSSN) and its association with atopic diseases and there is no consensus on the course of OSSN in atopic patients. We thereby report three patients with atopy and OSSN. Methods: Retrospective case series. Results: Three male patients with mean age of 73 presented with OSSN and history of atopy treated with immunosuppressant therapy. Their histories included atopic dermatitis and keratoconjunctivitis. All patients had treatment complicated by multiple surgeries, recurrences, or advanced disease. The patients initially received medical treatment with topical interferon-alpha-2b (IFNα2b). However, all the patients had recurrences and required modification of treatment including topical 5-fluorouracil (5-FU). Conclusion: We report on three patients with a history of atopy whose OSSN presentation and course was challenging. Overall, our cases responded better to topical 5-fluorouracil compared to topical interferon-alpha-2b, but recurrences were common. These patients may benefit from more aggressive and long-term treatment.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalOcular Immunology and Inflammation
DOIs
StateAccepted/In press - Nov 24 2017

Fingerprint

interferon alfa-2b
Neoplasms
Therapeutics
Recurrence
Fluorouracil
Keratoconjunctivitis
Atopic Dermatitis
Immunosuppressive Agents

Keywords

  • 5- fluorouracil
  • atopic disease
  • Atopy
  • interferon-alpha-2b
  • ocular surface squamous neoplasia
  • OSSN

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Cite this

Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease. / Zhang, Lily; Mercado, Carolina; Galor, Anat; Holland, Edward J.; Wang, Gaofeng; Karp, Carol.

In: Ocular Immunology and Inflammation, 24.11.2017, p. 1-6.

Research output: Contribution to journalArticle

@article{31e7b8e2ec0c448d8565d698ad7d86bc,
title = "Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease",
abstract = "Purpose: Few studies have described ocular surface squamous neoplasia (OSSN) and its association with atopic diseases and there is no consensus on the course of OSSN in atopic patients. We thereby report three patients with atopy and OSSN. Methods: Retrospective case series. Results: Three male patients with mean age of 73 presented with OSSN and history of atopy treated with immunosuppressant therapy. Their histories included atopic dermatitis and keratoconjunctivitis. All patients had treatment complicated by multiple surgeries, recurrences, or advanced disease. The patients initially received medical treatment with topical interferon-alpha-2b (IFNα2b). However, all the patients had recurrences and required modification of treatment including topical 5-fluorouracil (5-FU). Conclusion: We report on three patients with a history of atopy whose OSSN presentation and course was challenging. Overall, our cases responded better to topical 5-fluorouracil compared to topical interferon-alpha-2b, but recurrences were common. These patients may benefit from more aggressive and long-term treatment.",
keywords = "5- fluorouracil, atopic disease, Atopy, interferon-alpha-2b, ocular surface squamous neoplasia, OSSN",
author = "Lily Zhang and Carolina Mercado and Anat Galor and Holland, {Edward J.} and Gaofeng Wang and Carol Karp",
year = "2017",
month = "11",
day = "24",
doi = "10.1080/09273948.2017.1394470",
language = "English (US)",
pages = "1--6",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease

AU - Zhang, Lily

AU - Mercado, Carolina

AU - Galor, Anat

AU - Holland, Edward J.

AU - Wang, Gaofeng

AU - Karp, Carol

PY - 2017/11/24

Y1 - 2017/11/24

N2 - Purpose: Few studies have described ocular surface squamous neoplasia (OSSN) and its association with atopic diseases and there is no consensus on the course of OSSN in atopic patients. We thereby report three patients with atopy and OSSN. Methods: Retrospective case series. Results: Three male patients with mean age of 73 presented with OSSN and history of atopy treated with immunosuppressant therapy. Their histories included atopic dermatitis and keratoconjunctivitis. All patients had treatment complicated by multiple surgeries, recurrences, or advanced disease. The patients initially received medical treatment with topical interferon-alpha-2b (IFNα2b). However, all the patients had recurrences and required modification of treatment including topical 5-fluorouracil (5-FU). Conclusion: We report on three patients with a history of atopy whose OSSN presentation and course was challenging. Overall, our cases responded better to topical 5-fluorouracil compared to topical interferon-alpha-2b, but recurrences were common. These patients may benefit from more aggressive and long-term treatment.

AB - Purpose: Few studies have described ocular surface squamous neoplasia (OSSN) and its association with atopic diseases and there is no consensus on the course of OSSN in atopic patients. We thereby report three patients with atopy and OSSN. Methods: Retrospective case series. Results: Three male patients with mean age of 73 presented with OSSN and history of atopy treated with immunosuppressant therapy. Their histories included atopic dermatitis and keratoconjunctivitis. All patients had treatment complicated by multiple surgeries, recurrences, or advanced disease. The patients initially received medical treatment with topical interferon-alpha-2b (IFNα2b). However, all the patients had recurrences and required modification of treatment including topical 5-fluorouracil (5-FU). Conclusion: We report on three patients with a history of atopy whose OSSN presentation and course was challenging. Overall, our cases responded better to topical 5-fluorouracil compared to topical interferon-alpha-2b, but recurrences were common. These patients may benefit from more aggressive and long-term treatment.

KW - 5- fluorouracil

KW - atopic disease

KW - Atopy

KW - interferon-alpha-2b

KW - ocular surface squamous neoplasia

KW - OSSN

UR - http://www.scopus.com/inward/record.url?scp=85035793015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035793015&partnerID=8YFLogxK

U2 - 10.1080/09273948.2017.1394470

DO - 10.1080/09273948.2017.1394470

M3 - Article

SP - 1

EP - 6

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

ER -